Related Experiment Video

Updated: Aug 16, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

The role of atypical pathogens in community-acquired pneumonia

S K Gupta1, G A Sarosi

  • 1Division of Infectious Diseases, Indiana University School of Medicine, Indianapolis, Indiana, USA. sgupta1@iupui.edu

The Medical Clinics of North America
|October 30, 2001
PubMed

Insights

The term "atypical pathogens" for community-acquired pneumonia is outdated. Recent studies show these bacteria are similar to pneumococcus, and treatments are now standardized, making the distinction meaningless.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Pulmonary Medicine

Background:

  • Community-acquired pneumonia (CAP) traditionally involved atypical pathogens like Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella spp.
  • Recent research indicates these organisms share indistinguishable epidemiological and clinical characteristics with Streptococcus pneumoniae (pneumococcus).
  • Current therapeutic strategies for CAP do not rely on specific etiological identification.

Purpose of the Study:

  • To critically evaluate the continued relevance of the term "atypical pathogens" in the context of community-acquired pneumonia.
  • To discuss the implications of recent findings on pathogen identification and treatment.

Main Methods:

  • Review of recent epidemiological and clinical studies on community-acquired pneumonia pathogens.
  • Analysis of current diagnostic and therapeutic approaches for CAP.
  • Literature synthesis to assess the etiological classification of pneumonia-causing microorganisms.

Main Results:

  • Epidemiological and clinical data show Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella spp. are clinically indistinguishable from Streptococcus pneumoniae.
  • Treatment protocols for community-acquired pneumonia have evolved to be effective regardless of the specific bacterial agent.
  • Accurate etiological diagnosis of CAP remains challenging despite advancements in diagnostic methods.

Conclusions:

  • The distinction between typical and "atypical" pathogens in community-acquired pneumonia is no longer clinically or diagnostically meaningful.
  • The term "atypical" should be reconsidered due to the convergence of pathogen characteristics and treatment strategies.
  • Focus should shift towards improved diagnostic capabilities and standardized treatment approaches for CAP.

More Related Videos

Tools for the Real-Time Assessment of a Pseudomonas aeruginosa Infection Model07:39

Tools for the Real-Time Assessment of a Pseudomonas aeruginosa Infection Model

Published on: April 6, 2021

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...